NCI Director Kimryn Rathmell shared advice for the next generation of cancer researchers with members of the AACR Associate...
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
In the United States, advances in cancer research have dramatically improved outcomes for children diagnosed with cancer. While pediatric...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Despite tremendous progress against cancer in the past few decades, not all Americans have benefited equally from advances in...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The most recent edition of The Cancer Letter features an op-ed from AACR President David A. Tuveson, MD, PhD,...
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today The size of the known universe is mind-boggling. At times,...